• Market Share & Future Growth with forecasts of Orthopedic Implants Market Industry 2018 – 2025

Cone Midstream Partners LP (CNNX) Receives Average Rating of “Hold” from Analysts

More notable recent Magellan Midstream Partners, L.P. (NYSE:MMP) news were published by: Seekingalpha.com which released: “Report: Marathon Petroleum’s Galveston Bay refinery shutting down” on August 29, 2017, also Realmoney.Thestreet.com with their article: “Magellan Midstream Partners Is Back to Support: Here’s How to Play It” published on August 23, 2017, Seekingalpha.com published: “Magellan Midstream: Intriguing Assets And No IDRs” on September 05, 2017. Scotiabank set a $50.00 price objective on Noble…

Read More >>

Brokerages Set Rio Tinto PLC (RIO) Target Price at $47.67

Trading volume for Rio Tinto Plc was 1,986K on Friday. The Praesidium Investment Management Company Llc holds 2.27M shares with $104.99 million value, down from 2.31M last quarter. It fall, as 76 investors sold KO shares while 623 reduced holdings. Td Asset Management Inc who had been investing in Rio Tinto Plc for a number of months, seems to be bullish on the $87.00 billion market cap company. About shares…

Read More >>

How Many Huntsman Corporation (NYSE:HUN)’s Analysts Are Bearish?

The stock was sold at an average price of $25.76, for a total value of $1,459,948.00. Bronfman E.L. Rothschild L.P. now owns 5,385 shares of the basic materials company’s stock worth $139,000 after acquiring an additional 24 shares during the last quarter. Huntsman Corp now has $6.37 billion valuation. Its up 0.16, from 0.9 in 2016Q3. Victory Cap Mngmt reported 1.77 million shares or 0.09% of all its holdings. Amp…

Read More >>

Gem Diamonds Limited’s (GEMD) “Buy” Rating Reiterated at FinnCap

This would imply the analyst believes there is now a potential upside of 64.0% from today’s opening price of 80.5 GBX. The firm’s market capitalization is GBX 108.57 million. The Firm operates through the development and commercialization of Vascepa segment. The Company’s lead product, Vascepa capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult…

Read More >>